ARCHIVES

FDA Committee Can’t Find “Reasonable” Evidence Alkylating Agent Clinical Use Is Carcinogenic

This article is from The Cancer Letter archive.

Vol. 02 No. 37 | September 10, 1976

Download PDF Visit The Full Archive

Related Articles

Reauthorization Still Held up

September 30, 1988

NCI Director Says Research Budget Cuts Result in Untold “Missed Opportunities,” Provides List of Program Reductions.

March 9, 2007

Deals and Collaborations: Firms Get First Payment From Bristol-Myers for Taxol

March 5, 1999

Executive Branch Should Improve Science Pay, NAS Says

July 16, 1993

In Brief: NCAB to Hear Report On Treatment Programs, Discuss Hogness Plan For New Type of Review

November 3, 1978

GYN Group: Open Surgery Would Cost More Lives Than Morcellation

July 25, 2014